Lorcaserin

Rebalancing the Serotonergic System in Cocaine Dependence

A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Treatment With Lorcaserin for Cocaine Use: The TLC Study

Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects

Effect of Lorcaserin on Cannabis Withdrawal and Self-administration

Addressing Post Cessation Weight Gain

MEtformin and Lorcaserin for WeighT Loss in Schizophrenia

Lorcaserin for Cannabis Use Disorder

Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer

Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder

Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder

Lorcaserin in the Treatment of Cocaine Use Disorder

Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder

Gene-by-Stress Interactions in Intervention Studies Significance

Evaluating Muscle Weakness Improvement With Lorcaserin in ICU

Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic

Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder

Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age

Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic Impairment